{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:31:51Z","timestamp":1792024311098,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s12026-014-8496-1","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T03:01:33Z","timestamp":1394506893000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":196,"title":["The interplay between Epstein\u2013Barr virus and B lymphocytes: implications for infection, immunity, and disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Olivia L.","family":"Hatton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleishia","family":"Harris-Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Schaffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri M.","family":"Krams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"issue":"5","key":"8496_CR1","doi-asserted-by":"publisher","first-page":"e1001338","DOI":"10.1371\/journal.ppat.1001338","volume":"7","author":"C Shannon-Lowe","year":"2011","unstructured":"Shannon-Lowe C, Rowe M. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog. 2011;7(5):e1001338 (Epub 2011\/05\/17).","journal-title":"PLoS Pathog"},{"issue":"5","key":"8496_CR2","doi-asserted-by":"publisher","first-page":"e1002697","DOI":"10.1371\/journal.ppat.1002697","volume":"8","author":"E Heath","year":"2012","unstructured":"Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, Kube D, et al. Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog. 2012;8(5):e1002697 (Epub 2012\/05\/17).","journal-title":"PLoS Pathog"},{"issue":"4","key":"8496_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K, et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity. 2000;13(4):485\u201395 (Epub 2000\/11\/09).","journal-title":"Immunity"},{"issue":"22","key":"8496_CR4","doi-asserted-by":"publisher","first-page":"12330","DOI":"10.1128\/JVI.01699-12","volume":"86","author":"SI Tracy","year":"2012","unstructured":"Tracy SI, Kakalacheva K, Lunemann JD, Luzuriaga K, Middeldorp J, Thorley-Lawson DA. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol. 2012;86(22):12330\u201340 (Epub 2012\/09\/07).","journal-title":"J Virol"},{"issue":"4","key":"8496_CR5","doi-asserted-by":"publisher","first-page":"e1003220","DOI":"10.1371\/journal.ppat.1003220","volume":"9","author":"DF Angelini","year":"2013","unstructured":"Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, et al. Increased CD8\u00a0+\u00a0T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 2013;9(4):e1003220 (Epub 2013\/04\/18).","journal-title":"PLoS Pathog"},{"key":"8496_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587\u2013617.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"8496_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","volume":"187","author":"MF Callan","year":"1998","unstructured":"Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O\u2019Callaghan CA, et al. Direct visualization of antigen-specific CD8\u00a0+\u00a0T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med. 1998;187(9):1395\u2013402.","journal-title":"J Exp Med"},{"issue":"5","key":"8496_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.20121437","volume":"210","author":"HM Long","year":"2013","unstructured":"Long HM, Chagoury OL, Leese AM, Ryan GB, James E, Morton LT, et al. MHC II tetramers visualize human CD4\u00a0+\u00a0T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J Exp Med. 2013;210(5):933\u201349 (Epub 2013\/04\/10).","journal-title":"J Exp Med"},{"issue":"4","key":"8496_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00007890-200208270-00012","volume":"74","author":"DA Falco","year":"2002","unstructured":"Falco DA, Nepomuceno RR, Krams SM, Lee PP, Davis MM, Salvatierra O, et al. Identification of Epstein-Barr virus-specific CD8\u00a0+\u00a0T lymphocytes in the circulation of pediatric transplant recipients. Transplantation. 2002;74(4):501\u201310 Epub 2002\/09\/28.","journal-title":"Transplantation"},{"issue":"10","key":"8496_CR10","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.4049\/jimmunol.1001024","volume":"186","author":"C Macedo","year":"2011","unstructured":"Macedo C, Webber SA, Donnenberg AD, Popescu I, Hua Y, Green M, et al. EBV-specific CD8\u00a0+\u00a0T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function. J Immunol. 2011;186(10):5854\u201362 Epub 2011\/04\/05.","journal-title":"J Immunol."},{"issue":"2","key":"8496_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","volume":"129","author":"H Williams","year":"2005","unstructured":"Williams H, McAulay K, Macsween KF, Gallacher NJ, Higgins CD, Harrison N, et al. The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol. 2005;129(2):266\u201374 Epub 2005\/04\/09.","journal-title":"Br J Haematol"},{"issue":"6","key":"8496_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","volume":"5","author":"O Chijioke","year":"2013","unstructured":"Chijioke O, Muller A, Feederle R, Barros MH, Krieg C, Emmel V, et al. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein\u2013Barr virus infection. Cell Rep. 2013;5(6):1489\u201398 Epub 2013\/12\/24.","journal-title":"Cell Rep."},{"issue":"10","key":"8496_CR13","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","volume":"191","author":"A Lunemann","year":"2013","unstructured":"Lunemann A, Vanoaica LD, Azzi T, Nadal D, Munz C. A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol. 2013;191(10):4989\u201395 Epub 2013\/10\/11.","journal-title":"J Immunol."},{"issue":"6142","key":"8496_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1240094","volume":"341","author":"B Chaigne-Delalande","year":"2013","unstructured":"Chaigne-Delalande B, Li FY, O\u2019Connor GM, Lukacs MJ, Jiang P, Zheng L, et al. Mg2\u00a0+\u00a0regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013;341(6142):186\u201391 Epub 2013\/07\/13.","journal-title":"Science"},{"issue":"3","key":"8496_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med. 2000;192(3):337\u201346 Epub 2000\/08\/10.","journal-title":"J Exp Med"},{"issue":"4","key":"8496_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1086\/503269","volume":"78","author":"C Eidenschenk","year":"2006","unstructured":"Eidenschenk C, Dunne J, Jouanguy E, Fourlinnie C, Gineau L, Bacq D, et al. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet. 2006;78(4):721\u20137 Epub 2006\/03\/15.","journal-title":"Am J Hum Genet"},{"issue":"17","key":"8496_CR17","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","volume":"119","author":"RK Shaw","year":"2012","unstructured":"Shaw RK, Issekutz AC, Fraser R, Schmit P, Morash B, Monaco-Shawver L, et al. Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency. Blood. 2012;119(17):4009\u201312 Epub 2012\/03\/20.","journal-title":"Blood"},{"issue":"2","key":"8496_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-6143.2006.01650.x","volume":"7","author":"AL Snow","year":"2007","unstructured":"Snow AL, Martinez OM. Epstein-Barr virus: evasive maneuvers in the development of PTLD. Am J Transpl. 2007;7(2):271\u20137.","journal-title":"Am J Transpl."},{"issue":"1","key":"8496_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2042-4280-2-1","volume":"2","author":"S Ning","year":"2011","unstructured":"Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011;2(1):1 (Epub 2011\/03\/25).","journal-title":"Herpesviridae"},{"issue":"6","key":"8496_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.semcancer.2008.10.008","volume":"18","author":"ME Ressing","year":"2008","unstructured":"Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, et al. Epstein\u2013Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol. 2008;18(6):397\u2013408 Epub 2008\/11\/04.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"8496_CR21","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","volume":"8","author":"S Jochum","year":"2012","unstructured":"Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R. The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog. 2012;8(5):e1002704 (Epub 2012\/05\/23).","journal-title":"PLoS Pathog"},{"issue":"9","key":"8496_CR22","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1128\/JVI.73.9.7627-7632.1999","volume":"73","author":"JI Cohen","year":"1999","unstructured":"Cohen JI, Lekstrom K. Epstein\u2013Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J Virol. 1999;73(9):7627\u201332 (Epub 1999\/08\/10).","journal-title":"J Virol"},{"issue":"10","key":"8496_CR23","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20040191","volume":"199","author":"J Tellam","year":"2004","unstructured":"Tellam J, Connolly G, Green KJ, Miles JJ, Moss DJ, Burrows SR, et al. Endogenous presentation of CD8\u00a0+\u00a0T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med. 2004;199(10):1421\u201331 (Epub 2004\/05\/19).","journal-title":"J Exp Med"},{"issue":"4","key":"8496_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20031219","volume":"199","author":"KS Voo","year":"2004","unstructured":"Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein\u2013Barr virus nuclear antigen 1 peptides to CD8\u00a0+\u00a0T lymphocytes. J Exp Med. 2004;199(4):459\u201370 (Epub 2004\/02\/11).","journal-title":"J Exp Med"},{"issue":"8","key":"8496_CR25","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20070256","volume":"204","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, et al. A CD8\u00a0+\u00a0T cell immune evasion protein specific to Epstein\u2013Barr virus and its close relatives in old world primates. J Exp Med. 2007;204(8):1863\u201373 (Epub 2007\/07\/11).","journal-title":"J Exp Med"},{"issue":"5","key":"8496_CR26","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1128\/JVI.01946-07","volume":"82","author":"J Zuo","year":"2008","unstructured":"Zuo J, Thomas W, van Leeuwen D, Middeldorp JM, Wiertz EJ, Ressing ME, et al. The DNase of gammaherpesviruses impairs recognition by virus-specific CD8\u00a0+\u00a0T cells through an additional host shutoff function. J Virol. 2008;82(5):2385\u201393.","journal-title":"J Virol"},{"issue":"1","key":"8496_CR27","doi-asserted-by":"publisher","first-page":"e1000255","DOI":"10.1371\/journal.ppat.1000255","volume":"5","author":"J Zuo","year":"2009","unstructured":"Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, et al. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog. 2009;5(1):e1000255 (Epub 2009\/01\/03).","journal-title":"PLoS Pathog"},{"issue":"14","key":"8496_CR28","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1073\/pnas.0901036106","volume":"106","author":"AL Desbien","year":"2009","unstructured":"Desbien AL, Kappler JW, Marrack P. The Epstein\u2013Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc Natl Acad Sci U S A. 2009;106(14):5663\u20138 Epub 2009\/03\/19.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"8496_CR29","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.4049\/jimmunol.167.9.5404","volume":"167","author":"AL Snow","year":"2001","unstructured":"Snow AL, Chen LJ, Nepomuceno RR, Krams SM, Esquivel CO, Martinez OM. Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. J Immunol. 2001;167(9):5404\u201311 Epub 2001\/10\/24.","journal-title":"J Immunol."},{"issue":"5","key":"8496_CR30","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.4049\/jimmunol.177.5.3283","volume":"177","author":"AL Snow","year":"2006","unstructured":"Snow AL, Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM. EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis. J Immunol. 2006;177(5):3283\u201393 Epub 2006\/08\/22.","journal-title":"J Immunol."},{"issue":"34","key":"8496_CR31","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","volume":"267","author":"CD Laherty","year":"1992","unstructured":"Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM. The Epstein\u2013Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem. 1992;267(34):24157\u201360.","journal-title":"J Biol Chem"},{"issue":"7","key":"8496_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","volume":"65","author":"S Henderson","year":"1991","unstructured":"Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. Induction of bcl-2 expression by Epstein\u2013Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 1991;65(7):1107\u201315.","journal-title":"Cell"},{"issue":"20","key":"8496_CR33","first-page":"4610","volume":"56","author":"S Wang","year":"1996","unstructured":"Wang S, Rowe M, Lundgren E. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 1996;56(20):4610\u20133.","journal-title":"Cancer Res"},{"issue":"24","key":"8496_CR34","doi-asserted-by":"publisher","first-page":"18022","DOI":"10.1074\/jbc.M001202200","volume":"275","author":"SY Hong","year":"2000","unstructured":"Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and Epstein\u2013Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem. 2000;275(24):18022\u20138.","journal-title":"J Biol Chem"},{"key":"8496_CR35","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","volume":"90","author":"K Kaye","year":"1993","unstructured":"Kaye K, Izumi KM, Kieff E. Epstein Barr virus latent membrane protein 1 is essential for B lymphocyte growth transformation. Proc Natl Acad Sci U S A. 1993;90:9150\u20134.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3 Pt 2","key":"8496_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985;43(3 Pt 2):831\u201340.","journal-title":"Cell"},{"issue":"9","key":"8496_CR37","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","volume":"158","author":"PR Beatty","year":"1997","unstructured":"Beatty PR, Krams SM, Martinez OM. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol. 1997;158(9):4045\u201351 (Epub 1997\/05\/01).","journal-title":"J Immunol."},{"issue":"4","key":"8496_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00007890-199502270-00014","volume":"59","author":"OM Martinez","year":"1995","unstructured":"Martinez OM, Villanueva JC, Lawrence-Miyasaki L, Quinn MB, Cox K, Krams SM. Viral and immunologic aspects of Epstein\u2013Barr virus infection in pediatric liver transplant recipients. Transplantation. 1995;59(4):519\u201324 (Epub 1995\/02\/27).","journal-title":"Transplantation"},{"issue":"15","key":"8496_CR39","first-page":"4472","volume":"63","author":"RR Nepomuceno","year":"2003","unstructured":"Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Res. 2003;63(15):4472\u201380 (Epub 2003\/08\/09).","journal-title":"Cancer Res"},{"key":"8496_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221\u201341 (Epub 2012\/01\/10).","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"8496_CR41","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.4049\/jimmunol.179.12.8225","volume":"179","author":"SL Lambert","year":"2007","unstructured":"Lambert SL, Martinez OM. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol. 2007;179(12):8225\u201334.","journal-title":"J Immunol."},{"issue":"8","key":"8496_CR42","doi-asserted-by":"publisher","first-page":"e42610","DOI":"10.1371\/journal.pone.0042610","volume":"7","author":"O Hatton","year":"2012","unstructured":"Hatton O, Lambert SL, Krams SM, Martinez OM. Src kinase and Syk activation initiate PI3\u00a0K signaling by a chimeric latent membrane protein 1 in Epstein\u2013Barr virus (EBV)\u00a0+\u00a0B cell lymphomas. PLoS ONE. 2012;7(8):e42610.","journal-title":"PLoS ONE"},{"issue":"43","key":"8496_CR43","doi-asserted-by":"publisher","first-page":"37368","DOI":"10.1074\/jbc.M111.255125","volume":"286","author":"O Hatton","year":"2011","unstructured":"Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, Martinez OM. Syk activation of phosphatidylinositol 3-kinase\/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein\u2013Barr virus\u00a0+\u00a0(EBV\u00a0+) B cell lymphomas. J Biol Chem. 2011;286(43):37368\u201378 (Epub 2011\/09\/13).","journal-title":"J Biol Chem"},{"issue":"8","key":"8496_CR44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","volume":"83","author":"M Vaysberg","year":"2007","unstructured":"Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM. Rapamycin inhibits proliferation of Epstein\u2013Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation. 2007;83(8):1114\u201321.","journal-title":"Transplantation"},{"issue":"8","key":"8496_CR45","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1111\/ajt.12328","volume":"13","author":"S Furukawa","year":"2013","unstructured":"Furukawa S, Wei L, Krams SM, Esquivel CO, Martinez OM. PI3\u00a0K delta inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)\u00a0+\u00a0B cell lymphomas. Am J Transpl. 2013;13(8):2035\u201343 (Epub 2013\/07\/12).","journal-title":"Am J Transpl."},{"issue":"5671","key":"8496_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, et al. Identification of virus-encoded microRNAs. Science. 2004;304(5671):734\u20136.","journal-title":"Science"},{"issue":"12","key":"8496_CR47","doi-asserted-by":"publisher","first-page":"e1003018","DOI":"10.1371\/journal.ppat.1003018","volume":"8","author":"RP Kincaid","year":"2012","unstructured":"Kincaid RP, Sullivan CS. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 2012;8(12):e1003018 (Epub 2013\/01\/12).","journal-title":"PLoS Pathog"},{"issue":"4","key":"8496_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1600-6143.2010.03032.x","volume":"10","author":"A Harris","year":"2010","unstructured":"Harris A, Krams SM, Martinez OM. MicroRNAs as immune regulators: implications for transplantation. Am J Transpl. 2010;10(4):713\u20139 (Epub 2010\/03\/05).","journal-title":"Am J Transpl."},{"issue":"5824","key":"8496_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604\u20138 Epub 2007\/04\/28.","journal-title":"Science"},{"issue":"10","key":"8496_CR50","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102(10):3627\u201332 (Epub 2005\/03\/02).","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"8496_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207(2):243\u20139 Epub 2005\/07\/26.","journal-title":"J Pathol."},{"issue":"18","key":"8496_CR52","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1073\/pnas.0602266103","volume":"103","author":"S Costinean","year":"2006","unstructured":"Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006;103(18):7024\u20139 Epub 2006\/04\/28.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"8496_CR53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/QAD.0b013e3283543e0e","volume":"26","author":"DR Thapa","year":"2012","unstructured":"Thapa DR, Bhatia K, Bream JH, D\u2019Souza G, Rinaldo CR, Wolinsky S, et al. B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas. AIDS. 2012;26(9):1177\u201380 Epub 2012\/04\/11.","journal-title":"AIDS."},{"issue":"21","key":"8496_CR54","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1158\/0008-5472.CAN-04-1623","volume":"64","author":"S Bandyopadhyay","year":"2004","unstructured":"Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, et al. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res. 2004;64(21):7655\u201360 (Epub 2004\/11\/03).","journal-title":"Cancer Res"},{"issue":"7311","key":"8496_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 2010;467(7311):86\u201390 Epub 2010\/08\/10.","journal-title":"Nature"},{"issue":"1","key":"8496_CR56","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"RL Skalsky","year":"2012","unstructured":"Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012;8(1):e1002484 (Epub 2012\/02\/01).","journal-title":"PLoS Pathog"},{"issue":"52","key":"8496_CR57","doi-asserted-by":"publisher","first-page":"36573","DOI":"10.1074\/jbc.M802968200","volume":"283","author":"M Vaysberg","year":"2008","unstructured":"Vaysberg M, Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, et al. Tumor-derived variants of Epstein\u2013Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. J Biol Chem. 2008;283(52):36573\u201385 Epub 2008\/11\/07.","journal-title":"J Biol Chem"},{"issue":"11","key":"8496_CR58","first-page":"2131","volume":"7","author":"ML Chen","year":"1992","unstructured":"Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein\u2013Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene. 1992;7(11):2131\u201340 Epub 1992\/11\/01.","journal-title":"Oncogene"},{"issue":"10","key":"8496_CR59","first-page":"2129","volume":"12","author":"SN Li","year":"1996","unstructured":"Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein\u2013Barr virus. Oncogene. 1996;12(10):2129\u201335 Epub 1996\/05\/16.","journal-title":"Oncogene"},{"issue":"5","key":"8496_CR60","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/JVI.72.5.4038-4048.1998","volume":"72","author":"RJ Johnson","year":"1998","unstructured":"Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, et al. The 30-base-pair deletion in Chinese variants of the Epstein\u2013Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol. 1998;72(5):4038\u201348.","journal-title":"J Virol"},{"issue":"2","key":"8496_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","volume":"143","author":"CM Chang","year":"2009","unstructured":"Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K. The extent of genetic diversity of Epstein\u2013Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res. 2009;143(2):209\u201321 (Epub 2009\/07\/15).","journal-title":"Virus Res"},{"issue":"13","key":"8496_CR62","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1128\/JVI.00135-06","volume":"80","author":"BA Mainou","year":"2006","unstructured":"Mainou BA, Raab-Traub N. LMP1 strain variants: biological and molecular properties. J Virol. 2006;80(13):6458\u201368.","journal-title":"J Virol"},{"issue":"4","key":"8496_CR63","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1086\/314672","volume":"179","author":"DM Walling","year":"1999","unstructured":"Walling DM, Shebib N, Weaver SC, Nichols CM, Flaitz CM, Webster-Cyriaque J. The molecular epidemiology and evolution of Epstein\u2013Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J Infect Dis. 1999;179(4):763\u201374 Epub 1999\/03\/09.","journal-title":"J Infect Dis"},{"issue":"1","key":"8496_CR64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.V90.1.323.323_323_330","volume":"90","author":"K Sandvej","year":"1997","unstructured":"Sandvej K, Gratama JW, Munch M, Zhou XG, Bolhuis RL, Andresen BS, et al. Sequence analysis of the Epstein\u2013Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood. 1997;90(1):323\u201330.","journal-title":"Blood"},{"issue":"11","key":"8496_CR65","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1128\/JVI.77.11.6546-6550.2003","volume":"77","author":"DM Walling","year":"2003","unstructured":"Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. Multiple Epstein\u2013Barr virus infections in healthy individuals. J Virol. 2003;77(11):6546\u201350 Epub 2003\/05\/14.","journal-title":"J Virol"},{"issue":"5","key":"8496_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.icb.7100046","volume":"85","author":"S Pai","year":"2007","unstructured":"Pai S, O\u2019Sullivan B, Abdul-Jabbar I, Peng J, Connoly G, Khanna R, et al. Nasopharyngeal carcinoma-associated Epstein\u2013Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunol Cell Biol. 2007;85(5):370\u20137 (Epub 2007\/03\/21).","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"8496_CR67","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11373-005-9017-y","volume":"12","author":"HJ Lin","year":"2005","unstructured":"Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein\u2013Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. J Biomed Sci. 2005;12(6):925\u201336 Epub 2005\/11\/25.","journal-title":"J Biomed Sci"},{"issue":"5974","key":"8496_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"R Baer","year":"1984","unstructured":"Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, et al. DNA sequence and expression of the B95-8 Epstein\u2013Barr virus genome. Nature. 1984;310(5974):207\u201311 Epub 1984\/07\/19.","journal-title":"Nature"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-014-8496-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8496-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:32:59Z","timestamp":1744158779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-014-8496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":68,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["8496"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8496-1","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]},"assertion":[{"value":"12 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}